Summary

The global Molecular Diagnostic Reagent market size is predicted to grow from US$ 6626 million in 2025 to US$ 9975 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Molecular Diagnostic Reagent are mainly used in Molecular diagnostic approaches.It plays an essential role in patient care – providing physicians with the specific information required to identify and treat the very broad range of ailments presented across primary doctor or hospital practice settings.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Molecular Diagnostic Reagent Industry Forecast” looks at past sales and reviews total world Molecular Diagnostic Reagent sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostic Reagent sales for 2025 through 2031. With Molecular Diagnostic Reagent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostic Reagent industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostic Reagent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Diagnostic Reagent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Diagnostic Reagent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostic Reagent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostic Reagent.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostic Reagent market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Polymerase Chain Reaction PCR
Molecular Hybridization
Gene chip
Gene Sequencing
Segmentation by Application:
Infectious Disease Diagnosis
Genetic Diagnosis
Blood Screening
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Danaher Corporation
Hologic
Grifols
Biomérieux Sa
Qiagen
Abbott Laboratories
Thermo Fisher Scientific
Becton, Dickinson and Company
Illumina
Siemens AG
Agilent Technologies
DaAn Gene
Bio-Rad Laboratories
Diasorin
Merck KGaA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molecular Diagnostic Reagent market?
What factors are driving Molecular Diagnostic Reagent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molecular Diagnostic Reagent market opportunities vary by end market size?
How does Molecular Diagnostic Reagent break out by Type, by Application?

ページTOPに戻る

List of Tables/Graphs

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Diagnostic Reagent Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Molecular Diagnostic Reagent by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Molecular Diagnostic Reagent by Country/Region, 2020, 2024 & 2031
2.2 Molecular Diagnostic Reagent Segment by Type
2.2.1 Polymerase Chain Reaction PCR
2.2.2 Molecular Hybridization
2.2.3 Gene chip
2.2.4 Gene Sequencing
2.3 Molecular Diagnostic Reagent Sales by Type
2.3.1 Global Molecular Diagnostic Reagent Sales Market Share by Type (2020-2025)
2.3.2 Global Molecular Diagnostic Reagent Revenue and Market Share by Type (2020-2025)
2.3.3 Global Molecular Diagnostic Reagent Sale Price by Type (2020-2025)
2.4 Molecular Diagnostic Reagent Segment by Application
2.4.1 Infectious Disease Diagnosis
2.4.2 Genetic Diagnosis
2.4.3 Blood Screening
2.4.4 Other
2.5 Molecular Diagnostic Reagent Sales by Application
2.5.1 Global Molecular Diagnostic Reagent Sale Market Share by Application (2020-2025)
2.5.2 Global Molecular Diagnostic Reagent Revenue and Market Share by Application (2020-2025)
2.5.3 Global Molecular Diagnostic Reagent Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Molecular Diagnostic Reagent Breakdown Data by Company
3.1.1 Global Molecular Diagnostic Reagent Annual Sales by Company (2020-2025)
3.1.2 Global Molecular Diagnostic Reagent Sales Market Share by Company (2020-2025)
3.2 Global Molecular Diagnostic Reagent Annual Revenue by Company (2020-2025)
3.2.1 Global Molecular Diagnostic Reagent Revenue by Company (2020-2025)
3.2.2 Global Molecular Diagnostic Reagent Revenue Market Share by Company (2020-2025)
3.3 Global Molecular Diagnostic Reagent Sale Price by Company
3.4 Key Manufacturers Molecular Diagnostic Reagent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Diagnostic Reagent Product Location Distribution
3.4.2 Players Molecular Diagnostic Reagent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Molecular Diagnostic Reagent by Geographic Region
4.1 World Historic Molecular Diagnostic Reagent Market Size by Geographic Region (2020-2025)
4.1.1 Global Molecular Diagnostic Reagent Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Molecular Diagnostic Reagent Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Molecular Diagnostic Reagent Market Size by Country/Region (2020-2025)
4.2.1 Global Molecular Diagnostic Reagent Annual Sales by Country/Region (2020-2025)
4.2.2 Global Molecular Diagnostic Reagent Annual Revenue by Country/Region (2020-2025)
4.3 Americas Molecular Diagnostic Reagent Sales Growth
4.4 APAC Molecular Diagnostic Reagent Sales Growth
4.5 Europe Molecular Diagnostic Reagent Sales Growth
4.6 Middle East & Africa Molecular Diagnostic Reagent Sales Growth
5 Americas
5.1 Americas Molecular Diagnostic Reagent Sales by Country
5.1.1 Americas Molecular Diagnostic Reagent Sales by Country (2020-2025)
5.1.2 Americas Molecular Diagnostic Reagent Revenue by Country (2020-2025)
5.2 Americas Molecular Diagnostic Reagent Sales by Type (2020-2025)
5.3 Americas Molecular Diagnostic Reagent Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostic Reagent Sales by Region
6.1.1 APAC Molecular Diagnostic Reagent Sales by Region (2020-2025)
6.1.2 APAC Molecular Diagnostic Reagent Revenue by Region (2020-2025)
6.2 APAC Molecular Diagnostic Reagent Sales by Type (2020-2025)
6.3 APAC Molecular Diagnostic Reagent Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Molecular Diagnostic Reagent by Country
7.1.1 Europe Molecular Diagnostic Reagent Sales by Country (2020-2025)
7.1.2 Europe Molecular Diagnostic Reagent Revenue by Country (2020-2025)
7.2 Europe Molecular Diagnostic Reagent Sales by Type (2020-2025)
7.3 Europe Molecular Diagnostic Reagent Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Diagnostic Reagent by Country
8.1.1 Middle East & Africa Molecular Diagnostic Reagent Sales by Country (2020-2025)
8.1.2 Middle East & Africa Molecular Diagnostic Reagent Revenue by Country (2020-2025)
8.2 Middle East & Africa Molecular Diagnostic Reagent Sales by Type (2020-2025)
8.3 Middle East & Africa Molecular Diagnostic Reagent Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molecular Diagnostic Reagent
10.3 Manufacturing Process Analysis of Molecular Diagnostic Reagent
10.4 Industry Chain Structure of Molecular Diagnostic Reagent
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molecular Diagnostic Reagent Distributors
11.3 Molecular Diagnostic Reagent Customer
12 World Forecast Review for Molecular Diagnostic Reagent by Geographic Region
12.1 Global Molecular Diagnostic Reagent Market Size Forecast by Region
12.1.1 Global Molecular Diagnostic Reagent Forecast by Region (2026-2031)
12.1.2 Global Molecular Diagnostic Reagent Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Molecular Diagnostic Reagent Forecast by Type (2026-2031)
12.7 Global Molecular Diagnostic Reagent Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Molecular Diagnostic Reagent Product Portfolios and Specifications
13.1.3 Roche Diagnostics Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 Danaher Corporation
13.2.1 Danaher Corporation Company Information
13.2.2 Danaher Corporation Molecular Diagnostic Reagent Product Portfolios and Specifications
13.2.3 Danaher Corporation Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Danaher Corporation Main Business Overview
13.2.5 Danaher Corporation Latest Developments
13.3 Hologic
13.3.1 Hologic Company Information
13.3.2 Hologic Molecular Diagnostic Reagent Product Portfolios and Specifications
13.3.3 Hologic Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Hologic Main Business Overview
13.3.5 Hologic Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Molecular Diagnostic Reagent Product Portfolios and Specifications
13.4.3 Grifols Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 Biomérieux Sa
13.5.1 Biomérieux Sa Company Information
13.5.2 Biomérieux Sa Molecular Diagnostic Reagent Product Portfolios and Specifications
13.5.3 Biomérieux Sa Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Biomérieux Sa Main Business Overview
13.5.5 Biomérieux Sa Latest Developments
13.6 Qiagen
13.6.1 Qiagen Company Information
13.6.2 Qiagen Molecular Diagnostic Reagent Product Portfolios and Specifications
13.6.3 Qiagen Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Qiagen Main Business Overview
13.6.5 Qiagen Latest Developments
13.7 Abbott Laboratories
13.7.1 Abbott Laboratories Company Information
13.7.2 Abbott Laboratories Molecular Diagnostic Reagent Product Portfolios and Specifications
13.7.3 Abbott Laboratories Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Abbott Laboratories Main Business Overview
13.7.5 Abbott Laboratories Latest Developments
13.8 Thermo Fisher Scientific
13.8.1 Thermo Fisher Scientific Company Information
13.8.2 Thermo Fisher Scientific Molecular Diagnostic Reagent Product Portfolios and Specifications
13.8.3 Thermo Fisher Scientific Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Thermo Fisher Scientific Main Business Overview
13.8.5 Thermo Fisher Scientific Latest Developments
13.9 Becton, Dickinson and Company
13.9.1 Becton, Dickinson and Company Company Information
13.9.2 Becton, Dickinson and Company Molecular Diagnostic Reagent Product Portfolios and Specifications
13.9.3 Becton, Dickinson and Company Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Becton, Dickinson and Company Main Business Overview
13.9.5 Becton, Dickinson and Company Latest Developments
13.10 Illumina
13.10.1 Illumina Company Information
13.10.2 Illumina Molecular Diagnostic Reagent Product Portfolios and Specifications
13.10.3 Illumina Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Illumina Main Business Overview
13.10.5 Illumina Latest Developments
13.11 Siemens AG
13.11.1 Siemens AG Company Information
13.11.2 Siemens AG Molecular Diagnostic Reagent Product Portfolios and Specifications
13.11.3 Siemens AG Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Siemens AG Main Business Overview
13.11.5 Siemens AG Latest Developments
13.12 Agilent Technologies
13.12.1 Agilent Technologies Company Information
13.12.2 Agilent Technologies Molecular Diagnostic Reagent Product Portfolios and Specifications
13.12.3 Agilent Technologies Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Agilent Technologies Main Business Overview
13.12.5 Agilent Technologies Latest Developments
13.13 DaAn Gene
13.13.1 DaAn Gene Company Information
13.13.2 DaAn Gene Molecular Diagnostic Reagent Product Portfolios and Specifications
13.13.3 DaAn Gene Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 DaAn Gene Main Business Overview
13.13.5 DaAn Gene Latest Developments
13.14 Bio-Rad Laboratories
13.14.1 Bio-Rad Laboratories Company Information
13.14.2 Bio-Rad Laboratories Molecular Diagnostic Reagent Product Portfolios and Specifications
13.14.3 Bio-Rad Laboratories Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Bio-Rad Laboratories Main Business Overview
13.14.5 Bio-Rad Laboratories Latest Developments
13.15 Diasorin
13.15.1 Diasorin Company Information
13.15.2 Diasorin Molecular Diagnostic Reagent Product Portfolios and Specifications
13.15.3 Diasorin Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Diasorin Main Business Overview
13.15.5 Diasorin Latest Developments
13.16 Merck KGaA
13.16.1 Merck KGaA Company Information
13.16.2 Merck KGaA Molecular Diagnostic Reagent Product Portfolios and Specifications
13.16.3 Merck KGaA Molecular Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Merck KGaA Main Business Overview
13.16.5 Merck KGaA Latest Developments
14 Research Findings and Conclusion